Global Health LimitedMEDANTACorporate

Healthcare Medical Care Facilities Latest results: Jun 2026 15 quarters of data

₹1,240.00

MCap ₹33,321 Cr · P/E 69.2

Global Health Limited — Stock analysis & AI research Global Health Limited — Multibagger AI analysis Global Health Limited — Seasonality — best & worst months Global Health Limited — Technical indicators & charts Global Health Limited — Technical setup — score, trend, support & resistance Global Health Limited — Live exchange announcements

📋 Small Cap Stocks List 📈 RSI Oversold Stocks 📈 20-Day Breakdown Stocks 📈 Lowest Technical Score 🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹1,079 Cr

Sales · Jun 2026

+22.3% YoY

₹230 Cr

Operating Profit · Jun 2026

+18.0% YoY

21.3%

OPM % · Jun 2026

-3.6% YoY

₹137 Cr

Net Profit · Jun 2026

-9.6% YoY

₹5.11

EPS · Jun 2026

-9.7% YoY

📝 Global Health Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Global Health Limited reported revenue of ₹1,079 crore for the quarter ended June 2026 (Q1 FY27), up 22.3% from ₹882 crore in the same quarter last year, and up 12.3% sequentially over the March 2026 quarter.

Net profit fell 9.6% year-on-year to ₹137 crore, from ₹152 crore. Earnings per share (EPS) came in at ₹5.11.

Operating profit stood at ₹230 crore — an operating margin (OPM) of 21.3%, compared with 22.1% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Global Health Limited posted revenue of ₹3,710 crore, a growth of 37.2% over FY25, with a net profit of ₹496 crore (up 26.2% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹3,906 crore with a net profit of ₹481 crore.

Valuation snapshot

At the current price of ₹1,240.00, MEDANTA has a market capitalisation of ₹33,321 crore and a trailing P/E of about 69.2.

Within the Medical Care Facilities industry, it is the 6th-largest of the 11 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 33.00%, foreign institutional investors (FIIs) 9.46%, domestic institutional investors (DIIs) 16.89%, public shareholders 40.56% of Global Health Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹33,321 Cr

Current Price ?

₹1,240.0

P/E ?

69.22above ind

Industry P/E ?

56.40

P/B ?

8.30

P/S ?

8.53

P/FCF ?

-326.68

Enterprise Value ?

₹33,554 Cr

EV/EBITDA ?

42.50

PEG ?

3.01

Earnings Yield ?

1.8%

Dividend Yield ?

0.04%

Profitability & Returns

Sales (TTM) ?

₹3,906 Cr

OPM ?

20.2%

Profit after tax (TTM) ?

₹481 Cr

EPS (TTM) ?

₹17.92

ROCE ?

17.0%

ROE ?

12.0%

ROA ?

9.0%

Growth

Sales — latest qtr ?

₹1,079 Cr

PAT — latest qtr ?

₹137 Cr

YoY qtr sales growth ?

22.3%

YoY qtr profit growth ?

-9.6%

Sales growth (3y) ?

23%

Sales growth (5y) ?

25%

Profit growth (3y) ?

23%

Profit growth (5y) ?

54%

Financial Health

Debt ?

₹233 Cr

Debt to Equity ?

0.06

Interest Coverage ?

14.4

Current Ratio ?

N/A

Ownership

Promoter holding ?

33.00%

Change in promoter holding ?

-0.01%

Pledged percentage ?

N/A

Market

Return 3 months ?

-5.8%

Return 6 months ?

13.8%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	490	503	551	580	562	579	611	665	624	803	882	926	940	961	1,079	+22.3%	+12.3%
Operating Profit	95	103	115	128	123	122	132	150	140	195	195	193	174	193	230	+18.0%	+18.9%
Other Income	13	28	27	42	26	33	27	24	22	26	23	23	25	36	24	+4.0%	-33.2%
Interest	6	6	6	12	6	6	6	5	6	7	6	9	13	13	16	+180.8%	+22.2%
Depreciation	22	20	20	42	22	23	23	25	23	38	33	37	48	52	55	+63.4%	+5.0%
Profit Before Tax	80	104	116	243	121	125	130	144	132	126	198	185	103	163	183	-7.6%	+12.3%
Net Profit	59	81	86	95	87	92	96	104	99	93	152	140	80	124	137	-9.6%	+10.7%
EPS	2.25	3.02	3.21	3.54	3.25	3.43	3.58	3.89	3.70	3.48	5.66	5.22	2.97	4.62	5.11	-9.7%	+10.6%
OPM %	19.5%	20.4%	20.9%	22.1%	21.8%	21.1%	21.6%	22.6%	22.3%	24.3%	22.1%	20.8%	18.5%	20.1%	21.3%	-3.6%	+6.0%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹2,704 Cr	₹3,710 Cr	₹3,906 Cr	+37.2%
Operating Profit	₹617 Cr	₹755 Cr	₹789 Cr	+22.3%
OPM %	22.82%	20.34%	20.21%	-10.9%
NPM %	14.54%	13.37%	12.32%	-8.0%
Other Income	₹99 Cr	₹107 Cr	₹108 Cr	+8.2%
Depreciation	₹110 Cr	₹171 Cr	₹192 Cr	+55.6%
Interest	₹24 Cr	₹41 Cr	₹51 Cr	+69.3%
EBIT	₹507 Cr	₹584 Cr	₹598 Cr	+15.1%
PBT	₹532 Cr	₹649 Cr	₹634 Cr	+22.0%
Tax	₹99 Cr	₹114 Cr	₹114 Cr	+15.3%
Net Profit	₹393 Cr	₹496 Cr	₹481 Cr	+26.2%
EPS	₹14.65	₹18.47	₹17.92	+26.1%
Material Cost	₹490 Cr	₹599 Cr	₹631 Cr	+22.2%
Employee Cost	₹501 Cr	₹734 Cr	₹786 Cr	+46.4%
Extraordinary Items	₹-50 Cr	₹-71 Cr	₹-51 Cr	-41.9%

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	54	54	54	54	+0.0%
Reserves	2,435	2,983	3,444	3,959	+15.0%
Borrowings	288	424	337	233	-30.9%
Other Liabilities	402	523	606	1,105	+82.3%
Total Liabilities	3,179	3,984	4,441	5,351	+20.5%
Fixed Assets	810	1,645	1,861	2,903	+56.0%
CWIP	75	280	458	120	-73.8%
Investments	765	362	366	389	+6.3%
Other Assets	1,529	1,698	1,757	1,939	+10.4%
Total Assets	3,179	3,984	4,441	5,351	+20.5%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	431	559	528	573	+8.5%
Cash from Investing Activity	-257	-519	-638	-931	-45.9%
Cash from Financing Activity	404	-379	-94	264	+380.9%
Net Cash Flow	577	-339	-205	-94	+54.1%
Free Cash Flow	315	335	102	-102	-200.0%
CFO/OP	126%	97%	89%	90%	+1.1%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	32	26	33	38	+15.2%
Inventory Days	34	29	24	23	-4.2%
Days Payable	113	84	81	93	+14.8%
Cash Conversion Cycle	-48	-29	-24	-32	-33.3%
Working Capital Days	-27	-24	-14	-4	+71.4%
ROCE %	16%	23%	20%	17%	-15.0%

👥 Shareholding (latest 5 periods)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	% Chg
Promoters	33.01%	33.01%	33.01%	33.01%	33.00%	-0.0%
FIIs	11.54%	11.41%	10.54%	10.15%	9.46%	-6.8%
DIIs	12.20%	12.97%	13.99%	14.76%	16.89%	+14.4%
Public	43.19%	42.56%	42.41%	42.01%	40.56%	-3.5%
Others	0.06%	0.06%	0.06%	0.08%	—	—
No. of Shareholders	1,56,372	1,55,806	1,51,241	1,47,390	1,40,531	-4.7%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	APOLLOHOSP Apollo Hospitals	₹7,988.50	114,862	59.2	25,229	2,002	14.9%	7.9%	15.8%	33.1%	18.1%	32.9%
2	MAXHEALTH Max Healthcare	₹1,037.70	101,000	69.2	8,712	1,457	26.6%	16.7%	19.1%	34.1%	16.7%	4.9%
3	MANIPALHOS Manipal Health	₹710.85	93,504	—	—	—	—	—	—	—	28.2%	-8.3%
4	FORTIS Fortis Healthcare	₹887.80	67,025	64.3	9,128	1,064	22.8%	11.7%	17.3%	31.4%	17.8%	44.1%
5	ASTERDM Aster DM	₹763.50	66,552	198.5	4,876	363	19.0%	7.5%	44.2%	138.8%	21.6%	-68.9%
6	MEDANTA Global Health	₹1,445.60	38,846	69.8	4,683	553	20.9%	11.8%	19.4%	15.1%	26.5%	-1.1%
7	NH Narayana Hrudayalaya	₹1,869.90	37,978	46.6	9,073	817	19.3%	9.0%	41.4%	1.9%	78.0%	5.4%
8	KIMS Krishna Institute	₹767.50	30,711	148.9	4,214	194	19.8%	4.6%	28.7%	-41.5%	35.3%	-56.0%
9	RAINBOW Rainbow Children's	₹1,450.00	14,710	51.6	1,820	290	31.6%	15.9%	12.4%	15.2%	33.2%	16.2%
10	GAUDIUMIVF Gaudium IVF	₹116.42	847	36.4	106	23	32.9%	21.8%	—	—	9.1%	-42.2%
11	MOMSBELIEF Rays of Belief	₹223.00	466	—	—	—	—	—	—	—	136.4%	616.1%

❓ Frequently asked questions

What was Global Health Limited's revenue in Q1 FY27?

What was Global Health Limited's net profit in Q1 FY27?